Breast cancer and hormone-replacement therapy: The Million Women Study [2] (multiple letters)

Lancet

Volumn 362, Issue 9392, 2003, Pages 1328-1332

  Garton, Mark ^a   Bliss, Judith M ^b   Gray, Richard ^c   Bundred, N J ^d   Morris, Julie ^d   Helmond, Frans A ^e   Van Leeuwen, Flora E ^f   Rookus, Matti A ^f   Nyirjesy, Istvan ^g   Beral, Valerie ^h   Banks, Emily ^h   Reeves, Gillian ^h   Bull, Diana ^h   Yong, Stephen Put Yin ⁱ   Gray, Sarah ^j   Lagro Janssen, Toine ^k   Rosser, Walter W ^l   Van Weel, Chris ^k  

^a PERTH ROYAL INFIRMARY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e MERCK RESEARCH LABORATORIES   (United States)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g Intl Found Gynecologic Cancer D   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^j Code 229 HAG ^*  (United Kingdom)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l QUEEN S UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; TIBOLONE; DRUG COMBINATION;

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CLIMACTERIUM; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG USE; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; HEALTH BEHAVIOR; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; IRRITABILITY; LETHARGY; LETTER; MAMMOGRAPHY; MEDICAL INFORMATION; META ANALYSIS; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; ADVERSE EFFECTS; BREAST NEOPLASMS; CHEMICALLY INDUCED; DRUG COMBINATION; ESTROGEN THERAPY; FEMALE; INCIDENCE; PROCEDURES; PROSPECTIVE STUDY; RISK; RISK FACTOR;

BREAST NEOPLASMS; COHORT STUDIES; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; PROGESTINS; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 0142186272     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14590-4     Document Type: Letter

References (0)